XENEREX Trademark

Trademark Overview

On Wednesday, June 14, 2000, a trademark application was filed for XENEREX with the United States Patent and Trademark Office. The USPTO has given the XENEREX trademark a serial number of 76070843. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 26, 2013. This trademark is owned by Xenerex Biosciences. The XENEREX trademark is filed in the Pharmaceutical Products category with the following description:

Biochemicals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases
xenerex

General Information

Serial Number76070843
Word MarkXENEREX
Filing DateWednesday, June 14, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 26, 2013
Registration Number3187706
Registration DateTuesday, December 19, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 8, 2002

Trademark Statements

Goods and ServicesBiochemicals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 26, 2013
Primary Code005
First Use Anywhere DateTuesday, August 15, 2000
First Use In Commerce DateTuesday, March 2, 2004

Trademark Owner History

Party NameXenerex Biosciences
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameXenerex Biosciences
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameXenerex Biosciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, July 26, 2013CANCELLED SEC. 8 (6-YR)
Tuesday, December 19, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, November 14, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 3, 2006ASSIGNED TO LIE
Monday, October 30, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 14, 2006STATEMENT OF USE PROCESSING COMPLETE
Friday, September 15, 2006USE AMENDMENT FILED
Friday, September 15, 2006PAPER RECEIVED
Wednesday, April 19, 2006EXTENSION 5 GRANTED
Thursday, March 16, 2006EXTENSION 5 FILED
Thursday, March 16, 2006PAPER RECEIVED
Monday, September 19, 2005EXTENSION 4 GRANTED
Tuesday, September 13, 2005EXTENSION 4 FILED
Tuesday, September 13, 2005TEAS EXTENSION RECEIVED
Wednesday, April 20, 2005EXTENSION 3 GRANTED
Tuesday, March 15, 2005EXTENSION 3 FILED
Friday, March 18, 2005PAPER RECEIVED
Tuesday, September 28, 2004EXTENSION 2 GRANTED
Tuesday, September 14, 2004EXTENSION 2 FILED
Tuesday, March 30, 2004EXTENSION 1 GRANTED
Tuesday, March 16, 2004EXTENSION 1 FILED
Tuesday, September 14, 2004TEAS EXTENSION RECEIVED
Tuesday, August 17, 2004CASE FILE IN TICRS
Tuesday, March 30, 2004DIVISIONAL PROCESSING COMPLETE
Thursday, March 18, 2004DIVISIONAL REQUEST RECEIVED
Thursday, March 18, 2004PAPER RECEIVED
Monday, October 27, 2003PAPER RECEIVED
Tuesday, September 16, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 8, 2002TEAS CORR ADDRESS REQUEST RECEIVED BUT NOT PROCESSED LOC IS TTAB
Wednesday, February 6, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 8, 2002PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2001NOTICE OF PUBLICATION
Tuesday, September 18, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 4, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 5, 2001UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, November 20, 2000NON-FINAL ACTION MAILED
Thursday, November 9, 2000ASSIGNED TO EXAMINER

Related Keywords

xenerex diseases cancer treatment infectious diagnostic inflammatory genetic therapeutic clinical namely